Who owns iShares Dow Jones US Pharm Indx?

Key details on iShares Dow Jones US Pharm Indx (Ticker: IHE)

Who owns iShares Dow Jones US Pharm Indx?

Is IHE a good stock to own? Find out who bought iShares Dow Jones US Pharm Indx, who sold iShares Dow Jones US Pharm Indx (IHE) stock, and who holds a large position in iShares Dow Jones US Pharm Indx.

Fund Name Number of Shares Share Valuation As Of
Mandatum Life Insurance 678940 $692518 Dec. 31, 2015
BANK OF MONTREAL /CAN/ 317905 $54.81M March 31, 2015
MORGAN STANLEY 300124 $48.53M Dec. 31, 2015
Bank of America Corporation 260989 $38.78M Sept. 30, 2015
Niemann Capital Management 184992 $16.58M Sept. 30, 2012
LPL Financial 139325 $22.12M Dec. 31, 2015
Wells Fargo & Company 132730 $21.12M Dec. 31, 2015
Brookstone Capital Management 110398 $16.34M Sept. 30, 2015
Braver Wealth Management 100904 $14.94M Sept. 30, 2015
FMR 98689 $9.83M June 30, 2013
Royal Bank of Canada 96159 $14.23M Sept. 30, 2015
Brown Advisory Holdings Incorporated 88889 $14.37M Dec. 31, 2015
SPC Financial 80475 $13.01M Dec. 31, 2015
Raymond James & Associates 77957 $13.63M June 30, 2015
SPINNAKER TRUST 68084 $11.01M Dec. 31, 2015
Clark Capital Management 62550 $7.92M March 31, 2014
UBS Group AG 59168 $10.20M March 31, 2015
UBS AG 58779 $7.94M June 30, 2014
Rafferty Asset Management 57900 $5.77M June 30, 2013
CLS Investments 57000 $7.22M March 31, 2014
BANK HAPOALIM BM 56270 $1.61M March 31, 2015
Knight Capital 51820 $4.41M Dec. 31, 2012
Raymond James Financial Services Advisors 51353 $8.85M March 31, 2015
Guggenheim Capital, LLC Managers 51138 $4.25M March 31, 2012
GOLDMAN SACHS 50317 $7.45M Sept. 30, 2015

Who sold iShares Dow Jones US Pharm Indx?

Fund Name Date Sold Number of Shares Sold Share Valuation
RiverFront Investment March 31, 2010 73673 $4.40M